Pfizer is the world’s leading pharmaceutical company in negotiations with the Indian government for installation. On May 3, President and CEO Albert Burla announced that Pfizer’s BioNTech vaccine is ready for use in the country. Knowing that access to vaccines is important to end this pandemic.
Unfortunately, even though the application was submitted a few months ago, th vaccine is still not registered in India. Burla said in an email to Pfizer India: “We are currently discussing with the Indian government a shortcut to approve our Pfizer BioNTech vaccine, which will be marketed in India. In the past month, a pharmaceutical company was the Indian government. The vaccination program of China provides its non-commercial COVID-19 vaccine price.
A Pfizer spokesperson said: “We are continuing to negotiate with the government and are committed to making our vaccines available for use in India’s vaccination program. Currency control. The drugmaker also stated that its priority will be to provide vaccines to the government only. To assist the government. Failed to conduct local safety and immunogenicity studies. Directly with the United States Contacted by the Drug Administration of India (DCGI) to import the COVID-19 vaccine because the government has recently allowed to waive the obligation to provide local temporary test data in advance.
US Food and Drug Administration, European Medicines Agency (EMA), UK MHRA, or WHO Allen vaccine approved for emergency use list vaccines: All these regulatory agencies have approved Pfizer vaccines. Burla also said in an email that Pfizer will ship $70 million (more than Rs 510 crore) of medicines from its distribution centers in the United States, Europe and Asia to India. These drugs are identified as part of the India-19 treatment plan in India.
He said in his speech: We are deeply concerned about the emergency situation related to COVID-19 in India. We will wholeheartedly care about you, your loved ones and all people in India. The mail is that they are donating these drugs to ensure All COVID-19 patients in all public hospitals in the country have free access to Pfizer medicines they need. More than $70 million will be available immediately, and we will work closely with the government and our NGO partners to bring them to the greatest need The place.